Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Oxytocin to Promote Weight Loss in Children, Adolescents, and Adults With Brain Tumors and Hypothalamic Obesity Syndrome

NCT02849743 is registered in ClinicalTrials.gov with Shana McCormack, MD as lead sponsor.

NCT NCT02849743
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02849743 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Oxytocin to Promote Weight Loss in Children, Adolescents, and Adults With Brain Tumors and Hypothalamic Obesity Syndrome
Lead sponsor
Shana McCormack, MD
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2016
Completion date
May 31, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

craniopharyngioma, hypothalamic obesity